Navigation Links
China Medicine Corporation Obtains Australian Patent for rADTZ
Date:7/17/2008

Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

For more information, please contact:

Company Contact:

Ms. Huizhen Yu

Chief Financial Officer

China Medicine Corp.

Tel: +86-20-8739-1718

Email: konze
'/>"/>

SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
2. AmeriCares Purchases 2nd BLU-MED Deployable Field Hospital for China Earthquake Relief
3. Closing coal-burning power plant in China and improved cognitive development in children
4. China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
5. AmeriCares Meets Long-Term Health Needs of Disaster Victims in China and Myanmar
6. Chindexs United Family Healthcare Launches ChinaHealthWatch.org - A global resource for travelers to China
7. China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme
8. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
9. China Improves Safety Management on Imported Foods in Preparation for Olympic Games
10. AMDL Signs Letter of Intent to Purchase China-Based Pharmaceutical Distribution Company
11. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
Post Your Comments:
*Name:
*Comment:
*Email: